Works by Van Cutsem, Eric
Results: 141
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictive Value of Early Tumor Shrinkage and Density Reduction of Lung Metastases in Patients With Metastatic Colorectal Cancer Treated With Regorafenib.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: The role of anti-VEGF and anti-EGFR antibodies.
- Published in:
- Journal of Surgical Oncology, 2010, v. 102, n. 8, p. 937, doi. 10.1002/jso.21760
- By:
- Publication type:
- Article
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1600, doi. 10.1093/jnci/djt270
- By:
- Publication type:
- Article
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 21, p. 1635, doi. 10.1093/jnci/djs427
- By:
- Publication type:
- Article
Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery.
- Published in:
- Oncologist, 2010, v. 15, n. 4, p. 390, doi. 10.1634/theoncologist.2009-0233
- By:
- Publication type:
- Article
The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2007, v. 12, n. 1, p. 38, doi. 10.1634/theoncologist.12-1-38
- By:
- Publication type:
- Article
Challenges in the Use of Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer.
- Published in:
- Oncologist, 2006, v. 11, n. 9, p. 1010, doi. 10.1634/theoncologist.11-9-1010
- By:
- Publication type:
- Article
Clinical impact of using [<sup>18</sup>F]AlF‐NOTA‐octreotide PET/CT instead of [<sup>68</sup>Ga]Ga‐DOTA‐SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 8, p. 1, doi. 10.1111/jne.13420
- By:
- Publication type:
- Article
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy- Refractory Metastatic Colorectal Cancer Treated With Cetuximab.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 16, p. 1812, doi. 10.1001/jama.2010.1535
- By:
- Publication type:
- Article
Clinical characteristics and management of insulin-producing neuroendocrine carcinomas.
- Published in:
- Acta Gastro-Enterologica Belgica, 2016, v. 79, n. 3, p. 321
- By:
- Publication type:
- Article
Different surgical strategies in the treatment of familial adenomatous polyposis: what's the role of the ileorectal anastomosis?
- Published in:
- Acta Gastro-Enterologica Belgica, 2011, v. 74, n. 3, p. 435
- By:
- Publication type:
- Article
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
- Published in:
- Acta Gastro-Enterologica Belgica, 2011, v. 74, n. 3, p. 421
- By:
- Publication type:
- Article
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): A Belgian study.
- Published in:
- Human Mutation, 2005, v. 25, n. 2, p. 125, doi. 10.1002/humu.20122
- By:
- Publication type:
- Article
[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3033, doi. 10.1007/s00259-020-04918-4
- By:
- Publication type:
- Article
Al<sup>18</sup>F-NOTA-octreotide: first comparison with <sup>68</sup>Ga-DOTATATE in a neuroendocrine tumour patient.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Oncological Management of Unresectable Liver Metastases.
- Published in:
- Digestive Diseases, 2012, v. 30, p. 137, doi. 10.1159/000342047
- By:
- Publication type:
- Article
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2020425, doi. 10.1001/jamanetworkopen.2020.20425
- By:
- Publication type:
- Article
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1506075
- By:
- Publication type:
- Article
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study.
- Published in:
- Current Medical Research & Opinion, 2021, v. 37, n. 10, p. 1769, doi. 10.1080/03007995.2021.1940908
- By:
- Publication type:
- Article
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer.
- Published in:
- OncoTargets & Therapy, 2013, v. 6, p. 53, doi. 10.2147/OTT.S41383
- By:
- Publication type:
- Article
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-0821-z
- By:
- Publication type:
- Article
Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 10, p. 1312, doi. 10.1007/s11864-024-01261-w
- By:
- Publication type:
- Article
Association of Progression-free Survival, Overall Survival, and Patient-reported Outcomes by Skin Toxicity and KRAS Status in Patients Receiving Panitumumab Monotherapy.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 7, p. 1544, doi. 10.1002/cncr.24088
- By:
- Publication type:
- Article
18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 835, doi. 10.2967/jnumed.123.265622
- By:
- Publication type:
- Article
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 632, doi. 10.2967/jnumed.122.264563
- By:
- Publication type:
- Article
<sup>18</sup>F-AlF-NOTA-octreotide outperforms <sup>68</sup>Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264563
- By:
- Publication type:
- Article
Inflammation-based index and <sup>68</sup>Ga-DOTATOC PET-derived uptake and volumetric parameters predict outcome in neuroendocrine tumor patients treated with <sup> 90</sup>Y-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236935
- By:
- Publication type:
- Article
Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04145-z
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Investigating the Potential of Bevacizumab in Other Indications: Metastatic Renal Cell, Non-Small Cell Lung, Pancreatic and Breast Cancer.
- Published in:
- Oncology, 2005, v. 69, p. 46, doi. 10.1159/000088483
- By:
- Publication type:
- Article
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 2, p. 1, doi. 10.1093/jncics/pkac014
- By:
- Publication type:
- Article
Biomarker-driven Studies in Metastatic Colorectal Cancer (mCRC): Challenges and Opportunities.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 4, p. 37, doi. 10.13032/tjop.2052-5931.100113.
- By:
- Publication type:
- Article
Nivolumab Plus Ipilimumab vs Chemotherapy as First-Line Treatment for Microsatellite Instability-High/Mismatch Repair--Deficient Metastatic Colorectal Cancer: Expanded Efficacy Analysis From Checkmate 8HW.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 313
- By:
- Publication type:
- Article
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002
- By:
- Publication type:
- Article
Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quality of Life Analysis in Patients With RAS Wild-Type Metastatic Colorectal Cancer Treated With First-Line Cetuximab Plus Chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rationale and Design for the LUME-Colon 1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Nintedanib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Colorectal Cancer Refractory to Standard Treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Unraveling the Complexities of Treating Metastatic Colorectal Cancer With Angiogenesis Inhibitors.
- Published in:
- Clinical Colorectal Cancer, 2015, v. 14, n. 3, p. 131, doi. 10.1016/j.clcc.2015.05.001
- By:
- Publication type:
- Article
Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 156, doi. 10.1016/j.clcc.2014.04.001
- By:
- Publication type:
- Article
Comparison of KRAS Genotype: Therascreen Assay vs. LNA-Mediated qPCR Clamping Assay.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 195, doi. 10.1016/j.clcc.2013.05.001
- By:
- Publication type:
- Article
The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 179, doi. 10.1016/j.clcc.2013.04.004
- By:
- Publication type:
- Article
The Timing of Chemotherapy and Surgery for the Treatment of Colorectal Liver Metastases.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 4, p. 212, doi. 10.3816/CCC.2010.n.031
- By:
- Publication type:
- Article
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 4, p. 626, doi. 10.1007/s10120-023-01393-2
- By:
- Publication type:
- Article
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 197, doi. 10.1007/s10120-021-01227-z
- By:
- Publication type:
- Article
Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 6, p. 1330, doi. 10.1007/s10120-021-01200-w
- By:
- Publication type:
- Article